A phase I–II study of rituximab, ifosfamide, mitoxantrone andetoposide (R-IME) for B cell non-Hodgkin’s lymphoma prior to and after high-dose chemotherapy and autologous stem cell transplantation (HDC-ASCT)
Titel:
A phase I–II study of rituximab, ifosfamide, mitoxantrone andetoposide (R-IME) for B cell non-Hodgkin’s lymphoma prior to and after high-dose chemotherapy and autologous stem cell transplantation (HDC-ASCT)
Auteur:
Joyce, R.M. Regan, M. Ottaway, J. Umiel, T. Tetreault, J.-C. Levine, J. McDermott, D. Hurley, D. Giallombardo, N. Smith, T. Lamontagne, D. Uhl, L. Avigan, D.